Effects of the potential neuroleptic peptide des-tyrosine-gamma-endorphin and haloperidol on apomorphine-induced behavioural syndromes in rats and mice.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004723:Endorphins / Q000494:pharmacology*; D006220:Haloperidol / Q000494:pharmacology*; D006801:Humans; D008297:Male; D051379:Mice; D010446:Peptide Fragments / Q000494:pharmacology*; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects; D013045:Species Specificity; D013239:Stereotyped Behavior / Q000187:drug effects*
D004723:Endorphins; D010446:Peptide Fragments; D011954:Receptors, Dopamine; C018903:gamma-endorphin, des-Tyr(1)-; D006220:Haloperidol; D001058:Apomorphine